Barriers and enablers to deprescribing for people living with cystic fibrosis: Multidisciplinary perspectives
Enhancing self-efficacy through evidence-based guidelines and increasing feasibility by fostering collaborative approaches among HCPs and PwCF may improve deprescribing practices in CF care. As evidence on the benefits and safety of deprescribing grows, it should be integrated into clinical guidelines to alleviate medication burden and improve quality of life for PwCF.
Authors
- Justin P. Turner (ORCID: https://orcid.org/0000-0003-0613-108X)
- Emily Reeve (ORCID: https://orcid.org/0000-0002-1405-999X)
- Louise Lord (ORCID: https://orcid.org/0000-0001-8436-0932)
- Jenni Ilomäki (ORCID: https://orcid.org/0000-0002-0348-9441)
- Gina Shaw
- T. S. Wang
- Aili Langford (ORCID: https://orcid.org/0000-0003-0509-5136)
Institutions
- The Royal Melbourne Hospital (AU)
- University of South Australia (AU)
- Monash Health (AU)
- Alfred Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.rmed.2025.108091
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.52